Obesity and sleep apnea as a significant comorbidities in COVID-19 — A case report
| Autor: | Stefan Simovic, Danijela Djokovic, Katarina Pantic, Ivan Cekerevac, Danijela Bazic Sretenovic, Maja Nikolic, Nemanja Muric, Vuk Jokovic, Ljiljana Novkovic, Jovan Jovanovic |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
0301 basic medicine medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Endocrinology Diabetes and Metabolism Case Report 030209 endocrinology & metabolism Comorbidity Severity of Illness Index law.invention 03 medical and health sciences 0302 clinical medicine Risk Factors law Severity of illness medicine Humans In patient Obesity Intensive care medicine Sleep Apnea Obstructive 030109 nutrition & dietetics Nutrition and Dietetics Coronavirus disease 2019 SARS-CoV-2 business.industry Pulmonary embolism COVID-19 Sleep apnea Middle Aged medicine.disease Intensive care unit Hospitalization Intensive Care Units Obstructive sleep apnoea Respiratory Insufficiency business |
| Zdroj: | Obesity Research & Clinical Practice |
| ISSN: | 1871-403X |
| DOI: | 10.1016/j.orcp.2021.04.008 |
| Popis: | In our paper we aimed to increase the awareness among physicians, concerning coronavirus disease 2019 (COVID-19) severity, especially in patients with specific underlying comorbidities. Obesity is the second most common condition in hospitalized COVID-19 patients. Furthermore it has a major role in the development of obstructive sleep apnoea (OSA), which is highly involved in a severe COVID-19 development and its serious outcomes. Even though obese OSA patients had an increased pulmonary embolism (PE) risk, there is no enough evidence to support the interaction between obesity and OSA regarding PE development in the setting of COVID-19. Our patient is a 45-year-old obese male with COVID-19, who was admitted to the intensive care unit (ICU) with acute respiratory failure requiring high-flow nasal oxygenation. Clinical, laboratory and diagnostic findings pointed on severe COVID-19 form, complicated with PE. After recovery, the diagnosis of OSA was established. With this case, we wanted to alert the physicians on comorbidities, such as obesity and OSA, while those conditions, to some extent, may contribute to worse COVID-19 clinical presentation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect